What are the implications of erythromycin use in immunocompromised patients and how does its effectiveness compare to other antibiotics in preventing or treating opportunistic infections?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Erythromycin is less effective against opportunistic infections in immunocompromised patients compared to broader-spectrum antibiotics like fluoroquinolones or azithromycin.